Ticker brief
HROW HARROW INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$28.44
1 day
+1.0%
14 days
-3.1%
mkt cap
$1.6B
signals 14d
12
authors 14d
6
crowd 14d
-1.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 60% mid · 25 pctile own 1y | IV/HV 1.16× (as of 2026-08-21) |
| Skew — 25Δ RR 30d | -0.097 20 pctile own 1y | puts bid vs calls (downside bid) |
| Net dealer OI (NDOI) | +4.84 elevated | 5-session Δ +0.64 (as of 2026-06-10) |
| OI alarm | quiet | last alarm 2025-10-30 (z=3.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-15 · now +0.50 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @RevShark | B | +1.92 | 5 | -0.19 |
| @SixSigmaCapital | B | +0.16 | 2 | +0.62 |
| @MMMTwealth | A | -0.39 | 2 | +0.70 |
| @OptionsFlowBoss | C | · | 1 | +0.00 |
| @TheNewMoney_app | C | · | 1 | +0.35 |
| @KampnerSam | A | -1.38 | 1 | -0.50 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @MMMTwealth | +0.50 | Reports prior-day portfolio gain and completed positive performance by holding. | -1.1% | tweet ↗ |
| 2026-10-14 | @KampnerSam | -0.50 | Quantifies severe drawdowns across four eye-care pharmaceutical stocks. | +4.4% | tweet ↗ |
| 2026-10-13 | @MMMTwealth | +0.90 | Presents bull and conservative valuation cases implying substantial HROW upside. | +0.7% | tweet ↗ |
| 2026-10-12 | @SixSigmaCapital | +0.60 | Expects a strong second half for HROW. | -2.3% | tweet ↗ |
| 2026-10-09 | @RevShark | -0.25 | Questions an Opaleye-liquidation theory because ETON shows no similar move. | -3.1% | tweet ↗ |
| 2026-10-09 | @RevShark | +0.25 | Says HROW is recovering and attributes selling to losses from LQDA. | -3.1% | tweet ↗ |
| 2026-10-09 | @RevShark | -0.15 | Quantifies Opaleye's ownership and portfolio exposure to Harrow. | -3.1% | tweet ↗ |
| 2026-10-09 | @SixSigmaCapital | +0.65 | Added HROW at 27.44, bringing the average cost near 29. — Explicitly adds to an existing HROW position and states execution and average prices. | -3.1% | tweet ↗ |
| 2026-10-09 | @RevShark | -0.65 | Reports no technical support and continued biotech liquidation. | -3.1% | tweet ↗ |
| 2026-10-06 | @RevShark | -0.15 | Sees possible support at $30 but distrusts management, while suggesting guidance failures may be priced in. | -6.3% | tweet ↗ |
| 2026-10-05 | @TheNewMoney_app | +0.35 | Reports a large purchase of HROW 50 calls expiring in 2027. | -7.0% | tweet ↗ |
| 2026-10-05 | @OptionsFlowBoss | +0.00 | Flags an options roll-up requiring the linked chart. | -7.0% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.